2021
DOI: 10.1016/j.intimp.2020.107149
|View full text |Cite
|
Sign up to set email alerts
|

Mitoquinone ameliorates cigarette smoke-induced airway inflammation and mucus hypersecretion in mice

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
17
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
7
1

Relationship

1
7

Authors

Journals

citations
Cited by 19 publications
(18 citation statements)
references
References 39 publications
1
17
0
Order By: Relevance
“…Consistent with our findings, a previous study has also shown that inhibition of the NF-κB signaling pathway through blocking its translocation represses the release of pro-inflammatory proteins ( Ye et al, 2017 ). Notably, accumulating studies have identified that the airway inflammation is ascribed to the activation of the NF-κB signaling pathway ( Girkin et al, 2020 ; Yang H. et al, 2020 ; Yang D. et al, 2021 ). Our study here demonstrated that inhibitor of NF-κB blocked the extracellular ADP-induced release of CXCL10 in alveolar epithelial cells.…”
Section: Discussionmentioning
confidence: 99%
“…Consistent with our findings, a previous study has also shown that inhibition of the NF-κB signaling pathway through blocking its translocation represses the release of pro-inflammatory proteins ( Ye et al, 2017 ). Notably, accumulating studies have identified that the airway inflammation is ascribed to the activation of the NF-κB signaling pathway ( Girkin et al, 2020 ; Yang H. et al, 2020 ; Yang D. et al, 2021 ). Our study here demonstrated that inhibitor of NF-κB blocked the extracellular ADP-induced release of CXCL10 in alveolar epithelial cells.…”
Section: Discussionmentioning
confidence: 99%
“…Treatment. Mice were divided into 4 groups: a control group (n = 7) exposed to room air without treatment, and 3 experimental groups exposed to CS for 75 min twice daily, 5 days per week for 4 weeks [13]. One experimental group (CS group, n = 7) received no treatment; the SS-31 (L)+CS group (n = 8) was exposed to CS and treated with a low dose of SS-31 (2.5 mg/kg once daily) refer to the slightly modified dosage [14]; and the SS-31 (H)+CS group (n = 7) was exposed to CS and treated with a high dose of SS-31 (5 mg/kg once daily) [15,16].…”
Section: Cs Exposure and Animalmentioning
confidence: 99%
“…One experimental group (CS group, n = 7) received no treatment; the SS-31 (L)+CS group (n = 8) was exposed to CS and treated with a low dose of SS-31 (2.5 mg/kg once daily) refer to the slightly modified dosage [14]; and the SS-31 (H)+CS group (n = 7) was exposed to CS and treated with a high dose of SS-31 (5 mg/kg once daily) [15,16]. SS-31 (Topscience, Shanghai, China) was intraperitoneally injected 1 h before CS exposure [13,17]. After 4 weeks, all mice were sacrificed by intraperitoneal phenobarbital injection (Sigma-Aldrich, St. Louis, MO, USA) followed by exsanguination from the right ventricle and abdominal aorta.…”
Section: Cs Exposure and Animalmentioning
confidence: 99%
See 1 more Smart Citation
“…Wild-type (Rhot1 fl/fl ) and lung epithelial cell-specific Rhot1 KO mice (Rhot1 CreCC10 ) models were exposed to CS for 3 days duration (acute -Rhot1flp CreCC10)) and 4 months (chronic -Rhot1Flox CreCC10) (Both flp and flox techniques are based on the LoxP/Cre-mediated conditional gene KO and are widely used for studying gene specific functions), using Baumgartner-Jaeger CSM2082i (cigarette smoke generating machine; CH Technologies, Westwood, NJ, USA) (J. Chen et al, 2019;Sundar et al, 2010;Yang et al, 2021). All the air group mice were exposed to filtered room air and the same time duration was maintained as for the CS exposure.…”
Section: Animal Model and Exposurementioning
confidence: 99%